TELEMS: Feasibility of Remote Patient Visits in MS

Not Applicable

Completed

• Conditions: Multiple Sclerosis

• Registration Number: NCT04838990
• Lead Sponsor: Medical University of Vienna

Brief Summary

This trials randomizes patients with multiple sclerosis (MS, pwMS) to a remote visit (via phone or videochat) or a regular outpatient visit. Outcomes include satisfaction on the patients' and doctor's side.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-11-01
• Study First Submitted: 2021-02-21
• Study First Submitted QC: 2021-04-08
• Study First Posted: 2021-04-09
• Primary Completion: 2021-09-01
• Study Completion: 2021-10-01
• Status Verified: 2022-01
• Last Update Submitted: 2022-01-19
• Last Update Posted: 2022-01-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

• confirmed diagnosis of any type of MS
• own a phone/smartphone/computer
• informed consent

Exclusion Criteria

• language barriers

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
TMPQ	1 week after intervention	Telemedicine Perception questionnaire (17-85, higher scores are better)

Secondary Outcome Measures

Name	Time	Method
PPSM	1 week after intervention	Patient and Physician Satisfaction with monitoring (6-30, higher scores are better)

Trial Locations

Locations (1)

Medical University of Vienna; 🇦🇹 Vienna, Austria